Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease

A study in Japan

M. Kanai, E. Matsubara, K. Isoe, K. Urakami, K. Nakashima, H. Arai, H. Sasaki, Koji Abe, T. Iwatsubo, T. Kosaka, M. Watanabe, Y. Tomidokoro, M. Shizuka, K. Mizushima, T. Nakamura, Y. Igeta, Y. Ikeda, M. Amari, T. Kawarabayashi, K. Ishiguro & 5 others Y. Harigaya, K. Wakabayashi, K. Okamoto, S. Hirai, M. Shoji

Research output: Contribution to journalArticle

315 Citations (Scopus)

Abstract

To clarify the alterations of tau, amyloid β protein (Aβ) 1-40 and Aβ1-42(43) in the cerebrospinal fluid (CSF) that accompany normal aging and the progression of Alzheimer's disease (AD), CSF samples of 93 AD patients, 32 longitudinal subjects among these 93 AD patients, 33 patients with non-AD dementia, 56 with other neurological diseases, and 54 normal control subjects from three independent institutes were analyzed by sensitive enzyme-linked immunosorbent assays. Although the tau levels increased with aging, a significant elevation of tau and a correlation between the tau levels and the clinical progression were observed in the AD patients. A significant decrease of the Aβ1-42(43) levels and a significant increase of the ratio of Aβ1-40 to Aβ1-42(43) were observed in the AD patients. The longitudinal AD study showed continuous low Aβ1-42(43) levels and an increase of the ratio of Aβ1-40 to Aβ1-42(43) before the onset of AD. These findings suggest that CSF tau may increase with the clinical progression of dementia and that the alteration of the CSF level of Aβ1-42(43) and the ratio of Aβ1-40 to Aβ1- 42(43) may start at early stages in AD. The assays of CSF tau, Aβ1-40, and Aβ1-42(43) provided efficient diagnostic sensitivity (71%) and specificity (83%) by using the production of tau levels and the ratio of Aβ1-40 to Aβ1- 42(43), and an improvement in sensitivity (to 91%) was obtained in the longitudinal evaluation.

Original languageEnglish
Pages (from-to)17-26
Number of pages10
JournalAnnals of Neurology
Volume44
Issue number1
DOIs
Publication statusPublished - Jul 1998
Externally publishedYes

Fingerprint

Longitudinal Studies
Cerebrospinal Fluid
Japan
Alzheimer Disease
Dementia
Amyloidogenic Proteins
tau Proteins
Staphylococcal Protein A
Enzyme-Linked Immunosorbent Assay
Sensitivity and Specificity

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease : A study in Japan. / Kanai, M.; Matsubara, E.; Isoe, K.; Urakami, K.; Nakashima, K.; Arai, H.; Sasaki, H.; Abe, Koji; Iwatsubo, T.; Kosaka, T.; Watanabe, M.; Tomidokoro, Y.; Shizuka, M.; Mizushima, K.; Nakamura, T.; Igeta, Y.; Ikeda, Y.; Amari, M.; Kawarabayashi, T.; Ishiguro, K.; Harigaya, Y.; Wakabayashi, K.; Okamoto, K.; Hirai, S.; Shoji, M.

In: Annals of Neurology, Vol. 44, No. 1, 07.1998, p. 17-26.

Research output: Contribution to journalArticle

Kanai, M, Matsubara, E, Isoe, K, Urakami, K, Nakashima, K, Arai, H, Sasaki, H, Abe, K, Iwatsubo, T, Kosaka, T, Watanabe, M, Tomidokoro, Y, Shizuka, M, Mizushima, K, Nakamura, T, Igeta, Y, Ikeda, Y, Amari, M, Kawarabayashi, T, Ishiguro, K, Harigaya, Y, Wakabayashi, K, Okamoto, K, Hirai, S & Shoji, M 1998, 'Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease: A study in Japan', Annals of Neurology, vol. 44, no. 1, pp. 17-26. https://doi.org/10.1002/ana.410440108
Kanai, M. ; Matsubara, E. ; Isoe, K. ; Urakami, K. ; Nakashima, K. ; Arai, H. ; Sasaki, H. ; Abe, Koji ; Iwatsubo, T. ; Kosaka, T. ; Watanabe, M. ; Tomidokoro, Y. ; Shizuka, M. ; Mizushima, K. ; Nakamura, T. ; Igeta, Y. ; Ikeda, Y. ; Amari, M. ; Kawarabayashi, T. ; Ishiguro, K. ; Harigaya, Y. ; Wakabayashi, K. ; Okamoto, K. ; Hirai, S. ; Shoji, M. / Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease : A study in Japan. In: Annals of Neurology. 1998 ; Vol. 44, No. 1. pp. 17-26.
@article{735463989a044e7eb022d89acf64ba84,
title = "Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease: A study in Japan",
abstract = "To clarify the alterations of tau, amyloid β protein (Aβ) 1-40 and Aβ1-42(43) in the cerebrospinal fluid (CSF) that accompany normal aging and the progression of Alzheimer's disease (AD), CSF samples of 93 AD patients, 32 longitudinal subjects among these 93 AD patients, 33 patients with non-AD dementia, 56 with other neurological diseases, and 54 normal control subjects from three independent institutes were analyzed by sensitive enzyme-linked immunosorbent assays. Although the tau levels increased with aging, a significant elevation of tau and a correlation between the tau levels and the clinical progression were observed in the AD patients. A significant decrease of the Aβ1-42(43) levels and a significant increase of the ratio of Aβ1-40 to Aβ1-42(43) were observed in the AD patients. The longitudinal AD study showed continuous low Aβ1-42(43) levels and an increase of the ratio of Aβ1-40 to Aβ1-42(43) before the onset of AD. These findings suggest that CSF tau may increase with the clinical progression of dementia and that the alteration of the CSF level of Aβ1-42(43) and the ratio of Aβ1-40 to Aβ1- 42(43) may start at early stages in AD. The assays of CSF tau, Aβ1-40, and Aβ1-42(43) provided efficient diagnostic sensitivity (71{\%}) and specificity (83{\%}) by using the production of tau levels and the ratio of Aβ1-40 to Aβ1- 42(43), and an improvement in sensitivity (to 91{\%}) was obtained in the longitudinal evaluation.",
author = "M. Kanai and E. Matsubara and K. Isoe and K. Urakami and K. Nakashima and H. Arai and H. Sasaki and Koji Abe and T. Iwatsubo and T. Kosaka and M. Watanabe and Y. Tomidokoro and M. Shizuka and K. Mizushima and T. Nakamura and Y. Igeta and Y. Ikeda and M. Amari and T. Kawarabayashi and K. Ishiguro and Y. Harigaya and K. Wakabayashi and K. Okamoto and S. Hirai and M. Shoji",
year = "1998",
month = "7",
doi = "10.1002/ana.410440108",
language = "English",
volume = "44",
pages = "17--26",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease

T2 - A study in Japan

AU - Kanai, M.

AU - Matsubara, E.

AU - Isoe, K.

AU - Urakami, K.

AU - Nakashima, K.

AU - Arai, H.

AU - Sasaki, H.

AU - Abe, Koji

AU - Iwatsubo, T.

AU - Kosaka, T.

AU - Watanabe, M.

AU - Tomidokoro, Y.

AU - Shizuka, M.

AU - Mizushima, K.

AU - Nakamura, T.

AU - Igeta, Y.

AU - Ikeda, Y.

AU - Amari, M.

AU - Kawarabayashi, T.

AU - Ishiguro, K.

AU - Harigaya, Y.

AU - Wakabayashi, K.

AU - Okamoto, K.

AU - Hirai, S.

AU - Shoji, M.

PY - 1998/7

Y1 - 1998/7

N2 - To clarify the alterations of tau, amyloid β protein (Aβ) 1-40 and Aβ1-42(43) in the cerebrospinal fluid (CSF) that accompany normal aging and the progression of Alzheimer's disease (AD), CSF samples of 93 AD patients, 32 longitudinal subjects among these 93 AD patients, 33 patients with non-AD dementia, 56 with other neurological diseases, and 54 normal control subjects from three independent institutes were analyzed by sensitive enzyme-linked immunosorbent assays. Although the tau levels increased with aging, a significant elevation of tau and a correlation between the tau levels and the clinical progression were observed in the AD patients. A significant decrease of the Aβ1-42(43) levels and a significant increase of the ratio of Aβ1-40 to Aβ1-42(43) were observed in the AD patients. The longitudinal AD study showed continuous low Aβ1-42(43) levels and an increase of the ratio of Aβ1-40 to Aβ1-42(43) before the onset of AD. These findings suggest that CSF tau may increase with the clinical progression of dementia and that the alteration of the CSF level of Aβ1-42(43) and the ratio of Aβ1-40 to Aβ1- 42(43) may start at early stages in AD. The assays of CSF tau, Aβ1-40, and Aβ1-42(43) provided efficient diagnostic sensitivity (71%) and specificity (83%) by using the production of tau levels and the ratio of Aβ1-40 to Aβ1- 42(43), and an improvement in sensitivity (to 91%) was obtained in the longitudinal evaluation.

AB - To clarify the alterations of tau, amyloid β protein (Aβ) 1-40 and Aβ1-42(43) in the cerebrospinal fluid (CSF) that accompany normal aging and the progression of Alzheimer's disease (AD), CSF samples of 93 AD patients, 32 longitudinal subjects among these 93 AD patients, 33 patients with non-AD dementia, 56 with other neurological diseases, and 54 normal control subjects from three independent institutes were analyzed by sensitive enzyme-linked immunosorbent assays. Although the tau levels increased with aging, a significant elevation of tau and a correlation between the tau levels and the clinical progression were observed in the AD patients. A significant decrease of the Aβ1-42(43) levels and a significant increase of the ratio of Aβ1-40 to Aβ1-42(43) were observed in the AD patients. The longitudinal AD study showed continuous low Aβ1-42(43) levels and an increase of the ratio of Aβ1-40 to Aβ1-42(43) before the onset of AD. These findings suggest that CSF tau may increase with the clinical progression of dementia and that the alteration of the CSF level of Aβ1-42(43) and the ratio of Aβ1-40 to Aβ1- 42(43) may start at early stages in AD. The assays of CSF tau, Aβ1-40, and Aβ1-42(43) provided efficient diagnostic sensitivity (71%) and specificity (83%) by using the production of tau levels and the ratio of Aβ1-40 to Aβ1- 42(43), and an improvement in sensitivity (to 91%) was obtained in the longitudinal evaluation.

UR - http://www.scopus.com/inward/record.url?scp=14444269228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14444269228&partnerID=8YFLogxK

U2 - 10.1002/ana.410440108

DO - 10.1002/ana.410440108

M3 - Article

VL - 44

SP - 17

EP - 26

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 1

ER -